Overview

Evaluation and Validation of Endogenous Markers for the Assessment of CYP3A Activity in Korean Healthy Subjects Using Metabolomics

Status:
Completed

Trial end date:
2016-04-01

Target enrollment:

Participant gender:

Summary

The study objective is to evaluate and validate of endogenous markers for the assessment of CYP3A activity in Korean healthy subjects using metabolomics. In part 1, total 75 healthy subjects (males and females) will be enrolled. In part 2, total 25 healthy female subject aged 20-45 years will be enrolled. In both part A and B, subjects will be administered midazolam I.V. 1 mg.

Phase:

Phase 1

Details

Lead Sponsor:

Seoul National University Hospital

Treatments:

Midazolam